Vascular Endothelial Growth Factor (VEGF) antibody and antigen (Recombinant protein)
Diagnostic Vascular Endothelial Growth Factor (VEGF) antibodies (anti-Vascular Endothelial Growth Factor, anti-VEGF) and antigens (recombinant Vascular Endothelial Growth Factor (VEGF) protein) for Cardiovascular disease VEGF detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Cardiovascular disease diagnostics products collection
>>
Product information
Size: 1mg | 10mg | 100mg
Catalog No. | Description | US $ Price (per mg) | First Order Discount | First Order Discount Price |
---|---|---|---|---|
GMP-h-VEGF-Ag01 | Recombinant human VEGFA/VEGF Protein | 3090 | ||
GMP-h-VEGF-Ab01 | Anti-human VEGFA/VEGF mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-h-VEGF-Ab02 | Anti-human VEGFA/VEGF mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-h-VEGF-Ab03 | Anti-human VEGFA/VEGF human monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-h-VEGF-Ab04 | Anti-human VEGFA/VEGF human monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)
Product Description
Cat No. of Products | GMP-h-VEGF-Ag01 |
Product Name | Recombinant human VEGFA/VEGF Protein |
Target/Biomarker | Vascular Endothelial Growth Factor (VEGF) |
Alias of Target/Biomarker | L-VEGF, MVCD1, VEGF, VPF |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Vascular Endothelial Growth Factor (VEGF) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VEGF level test of Cardiovascular disease (angiogenesis) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human VEGFA/VEGF Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-VEGF-Ab01, GMP-h-VEGF-Ab02 |
Product Name | Anti-human VEGFA/VEGF mouse monoclonal antibody (mAb) |
Target/Biomarker | Vascular Endothelial Growth Factor (VEGF) |
Alias of Target/Biomarker | L-VEGF, MVCD1, VEGF, VPF |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human Vascular Endothelial Growth Factor (VEGF) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Vascular Endothelial Growth Factor (VEGF) antibodies in VEGF level test of Cardiovascular disease (angiogenesis) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human VEGFA/VEGF mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-VEGF-Ab03, GMP-h-VEGF-Ab04 |
Product Name | Anti-human VEGFA/VEGF human monoclonal antibody (mAb) |
Target/Biomarker | Vascular Endothelial Growth Factor (VEGF) |
Alias of Target/Biomarker | L-VEGF, MVCD1, VEGF, VPF |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human Vascular Endothelial Growth Factor (VEGF) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Vascular Endothelial Growth Factor (VEGF) antibodies in VEGF level test of Cardiovascular disease (angiogenesis) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human VEGFA/VEGF human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Vascular endothelial growth factor (VEGF), originally known as vascular permeability factor (VPF), is a signal protein produced by many cells that stimulates the formation of blood vessels. VEGF has important roles in mammalian vascular development and in diseases involving abnormal growth of blood vessels; other VEGFs are also involved in the development of lymphatic vessels and disease-related angiogenesis
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.